PMID- 37091811 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230425 IS - 2590-0064 (Electronic) IS - 2590-0064 (Linking) VI - 20 DP - 2023 Jun TI - Biomimetic liposomes hybrid with erythrocyte membrane modulate dendritic cells to ameliorate systemic lupus erythematosus. PG - 100625 LID - 10.1016/j.mtbio.2023.100625 [doi] LID - 100625 AB - Dendritic cells (DCs)-based immunotherapy has shown immense promise in systemic lupus erythematosus (SLE) treatment. However, existing carrier strategies such as polymers, liposomes, and polypeptides, are difficult to achieve active targeting to DCs due to their intricate interaction with biological systems. Since DCs represent a class of phagocytes responsible for the removal of senescent or damaged erythrocytes, we hypothesize that hybrid vesicles containing erythrocytes membrane components could be presented to be potent drug carriers to target DCs specifically. Herein, inspired by the cell membrane fusion technique, we develop hybrid biomimetic liposomes (R-Lipo) by fusing natural erythrocyte membrane vesicles and artificial liposomes for DCs-targeted SLE therapy. The resultant R-Lipo exhibited excellent biocompatibility and was shown to be effectively internalized by DCs both in vitro and in vivo. Using an immunosuppressant, mycophenolic acid (MPA), as the model drug, MPA-loaded R-Lipo powerfully suppressed DCs maturation and efficiently controlled the duration of lupus nephritis without apparent side effects. Our findings provide a safe, effective, and easy-to-prepare biomimetic vesicle platform for the treatment of SLE and other DC-associated diseases. CI - (c) 2023 Published by Elsevier Ltd. FAU - Hao, Xubin AU - Hao X AD - Department of Rheumatology and Immunology, Institute of Translational Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China. FAU - Gan, Jingjing AU - Gan J AD - Department of Rheumatology and Immunology, Institute of Translational Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China. FAU - Cao, Juan AU - Cao J AD - Department of Geriatrics, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China. FAU - Zhang, Dagan AU - Zhang D AD - Department of Rheumatology and Immunology, Institute of Translational Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China. FAU - Liang, Jun AU - Liang J AD - Department of Rheumatology and Immunology, Institute of Translational Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China. FAU - Sun, Lingyun AU - Sun L AD - Department of Rheumatology and Immunology, Institute of Translational Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China. LA - eng PT - Journal Article DEP - 20230401 PL - England TA - Mater Today Bio JT - Materials today. Bio JID - 101757228 PMC - PMC10114516 OTO - NOTNLM OT - Biomimetic liposome OT - Erythrocyte OT - Hybrid cell membrane OT - Mycophenolic acid OT - Systemic lupus erythematosus COIS- The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/04/24 06:42 MHDA- 2023/04/24 06:43 PMCR- 2023/04/01 CRDT- 2023/04/24 04:00 PHST- 2023/02/06 00:00 [received] PHST- 2023/03/20 00:00 [revised] PHST- 2023/03/31 00:00 [accepted] PHST- 2023/04/24 06:43 [medline] PHST- 2023/04/24 06:42 [pubmed] PHST- 2023/04/24 04:00 [entrez] PHST- 2023/04/01 00:00 [pmc-release] AID - S2590-0064(23)00085-6 [pii] AID - 100625 [pii] AID - 10.1016/j.mtbio.2023.100625 [doi] PST - epublish SO - Mater Today Bio. 2023 Apr 1;20:100625. doi: 10.1016/j.mtbio.2023.100625. eCollection 2023 Jun.